News

As a leading biotechnology company, Innovative Research thought it would be interesting to provide you with a few facts you may or may not be aware of about the products manufactured by biotech companies.

While the manufacturing of products to be used in life sciences, cancer and other research has been going on for decades, human insulin (specifically Humulin) was the first biotechnology drug to be approved by the FDA. Humulin was developed by Genentech in 1982 and was used for treatment of diabetes.

Read more →


Innovative Research's Pooled Normal Human Serum was recently used in the following studies:

Immunoproteomically Identified GBAA_0345, Alkyl Hydroperoxide Reductase Subunit C is a Potential Target for Multivalent Anthrax Vaccine

YH Kim, K Kim, YR Kim, MK Choi, HK Kim, KJ Choi... - Proteomics, 2013
immunoproteomic analyses. A pooled sample of normal human sera was purchased from Innovative Research Inc. (Peary Court Novi, MI, USA). Sera from five patients with anthrax werealso used in this study. These patients contracted anthrax during Korean outbreaks in...

Read more →


Innovative Research is quickly moving to the forefront of cancer research and development. We now offer several types of cancer plasma, cancer serum, and tissue samples. These high quality reagents are available from a variety of different types of cancer including breast cancer, carcinoma, cervix, colon, head and neck and much more. Multiple stages are available and all samples are available from various types of donors. Innovative hopes by providing high quality cancer research material that one day with further research and development we can find a cure for cancer.

Read more →



×